Archive: 23/09/2014
Drugs approved to treat other cancer types may improve treatment outcome for a type of childhood leukemia
Tyrosine kinase inhibitors (TKIs) may improve treatment outcome for children and young adults with Ph-like acute lymphoblastic leukemia (Ph-like ALL), a disease with dismal prognosis, according to data presented at the American ...
Sep 23, 2014
Medical students who previously attended community college more likely to serve in poor communities
The community college system represents a potential source of student diversity for medical schools and physicians who will serve poor communities; however, there are significant challenges to enhancing the pipeline from ...
Sep 23, 2014
Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukemia and multiple myeloma
The investigational drug CX-5461, which blocks the protein RNA polymerase I (Pol I), prolonged survival in mouse models of highly aggressive acute myeloid leukemia (AML) and multiple myeloma, according to data presented at ...
Sep 23, 2014
New type of targeted therapy shows promise in preclinical models of B-cell malignancy
An investigational, bacterial toxin-based therapy targeted to the protein CD38, which is found on the surface of many human blood cancer cells, including multiple myeloma cells, dramatically increased survival in mice bearing ...
Sep 23, 2014